Type IV hypersensitivity disease
MONDO:0002459A disease that has its basis in the disruption of type IV hypersensitivity.
Also known as: DTH, delayed hypersensitivity reaction, delayed-type hypersensitivity, delayed-type hypersensitivity response, disorder of type IV hypersensitivity, type 4 hypersensitivity reaction, type IV hypersensitivity, type IV hypersensitivity reaction
19 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Needle-Free epinephrine film could transform emergency allergy care for kids
Disease control CompletedThis study tests a new dissolving film called DESF that delivers epinephrine under the tongue. It is designed for children ages 7 to 17 who weigh at least 30 kg and have a history of allergic reactions that put them at high risk for severe episodes like anaphylaxis. The goal is t…
Phase: PHASE1 • Sponsor: Aquestive Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Experimental IL-2 treatment shows promise for Hard-to-Treat HCV vasculitis
Disease control CompletedThis study tested a drug called interleukin-2 (IL-2) in 10 people with hepatitis C-related vasculitis that did not get better with usual treatments. The goal was to see if IL-2 could boost the body's immune regulation and control the disease. Participants received IL-2 injections…
Phase: PHASE1, PHASE2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Vitamin d levels checked for clues to heart risk in kidney patients
Knowledge-focused CompletedThis study looked at whether vitamin D levels in the blood are related to early signs of artery hardening (atherosclerosis) in people on dialysis. Researchers measured vitamin D and used ultrasound to check artery thickness in 90 adults with kidney failure. The goal was to see if…
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Hospital staff antibody study tracks COVID-19 immunity over a year
Knowledge-focused CompletedThis study looked at how many hospital workers had COVID-19 antibodies and how long they lasted. Over 500 staff at a French cancer center gave blood samples and answered questionnaires at the start, 3 months, and 12 months. The goal was to understand immune response in people who…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:35 UTC